Shifting Patterns of Colorectal Cancer Burden in the United States (1999–2023): Implications for Precision Medicine Strategies and Drug Resistance in Early-Onset Colorectal Cancer

Journal article

Background: Colorectal cancer (CRC) remains one of the common causes of cancer-related morbidity and mortality in the United States. Emerging increases in early-onset CRC and persistent disparities remain major public health concerns. Objective: To characterize long-term CRC incidence and mortality trends in the United States, with particular emphasis on identifying demographic groups experiencing rising or plateauing disease burden. Methods: We conducted a population-based ecological study using CRC incidence data from the United States Cancer Statistics database (1999–2022) and mortality data from CDC WONDER (1999–2023). Temporal trends were evaluated using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC), stratified by age, sex, race/ethnicity, and urbanization level. Results: Overall CRC incidence and mortality declined during the study period (both AAPC approximately −2.08%). However, incidence increased significantly among adults younger than 55 years, particularly those aged 20–24 years. Mortality also increased among younger adults aged 25–44 years and remained elevated among individuals aged 45–54 years. Non-Hispanic Black individuals consistently experienced the highest incidence and mortality rates. Mortality declines plateaued in several older age groups after 2018–2020. Conclusions: Despite overall improvements in CRC burden, increasing incidence and mortality among younger adults and persistent disparities highlight the need for risk-stratified prevention, earlier detection strategies, and tailored therapeutic approaches.

Authors: Sun, C; Liu, L; Lees, EH; Billstein, LE; Zou, Y

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: MDPI
• Journal: Cancers
• Volume: 18
• Issue: 11
• Pages: 1768
• Article number: 1768
• Publication date: 2026-05-28
• Acceptance date: 2026-05-26
• DOI: 10.3390/cancers18111768
• EISSN: 2072-6694
• ISSN: 2072-6694
• Language: English
• Keywords: precision medicine; drug resistance; colorectal cancer; early-onset cancer; health disparities; risk stratification